Chemical Structure (Caprelsa 01)
Caprelsa Tablet, Film Coated
Product Images NDC 58468-7840
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Caprelsa (NDC 58468-7840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Caprelsa 02)
Principal Display Panel (100 mg Tablet Bottle Label)
This is a medication label for Caprelsa (Vandetanib) tablets, manufactured in Switzerland by Genzyme Gorporation. The label includes dosage instructions, warnings to keep the medication out of reach of children, and storage instructions. It also includes the manufacturer's contact information and the NDC (National Drug Code). The medication guide is enclosed with the package and should be dispensed to each patient.*
Principal Display Panel (100 mg Tablet Bottle Carton)
Caprelsa is a medication in tablet form containing vandetanib. It is used for treating specific types of thyroid cancer. The prescription comes with a medication guide that is to be given to each patient. Caprelsa is registered under the trademark of Genzyme Corporation and manufactured in Switzerland. The tablets should be stored at room temperature between 68°F and 77°F (20°C and 25°C) with permitted excursions allowed to 59°F-86°F (15°C-30°C). The prescription should be kept out of reach of children. For more information, contact Genzyme support services at 1-800-745-4447 (Option 3).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
